| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A BCMAxCD3 bispecific T cell–engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells
|
DiLillo, David J.
|
|
|
|
5 |
p. 1291-1304
|
artikel
|
| 2 |
A CRISPR RNA-binding protein screen reveals regulators of RUNX1 isoform generation
|
Davis, Amanda G.
|
|
|
|
5 |
p. 1310-1323
|
artikel
|
| 3 |
Activity of brentuximab vedotin in AIDS-related primary effusion lymphoma
|
Chang, Victoria A.
|
|
|
|
5 |
p. 766-768
|
artikel
|
| 4 |
Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes
|
Paudel, B. Bishal
|
|
|
|
5 |
p. 1137-1142
|
artikel
|
| 5 |
Add-on erythropoietin in autoimmune hemolytic anemia
|
Moser, Miriam M.
|
|
|
|
5 |
p. 1320-1321
|
artikel
|
| 6 |
Advanced practice providers in hematology: actionable findings from national paired APP and physician surveys
|
Marshall, Ariela L.
|
|
|
|
5 |
p. 1179-1189
|
artikel
|
| 7 |
A neutrophil activation signature predicts critical illness and mortality in COVID-19
|
Meizlish, Matthew L.
|
|
|
|
5 |
p. 1164-1177
|
artikel
|
| 8 |
An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphoma
|
Flümann, Ruth
|
|
|
|
5 |
p. 1063-1074
|
artikel
|
| 9 |
A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia
|
Nair-Gupta, Priyanka
|
|
|
|
5 |
p. 906-919
|
artikel
|
| 10 |
A novel method to generate T-cell receptor–deficient chimeric antigen receptor T cells
|
Kamiya, Takahiro
|
|
|
|
5 |
p. 517-528
|
artikel
|
| 11 |
Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors
|
Miller, Eric J.
|
|
|
|
5 |
p. 1559-1565
|
artikel
|
| 12 |
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001
|
Uy, Geoffrey L.
|
|
|
|
5 |
p. 331-340
|
artikel
|
| 13 |
A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation
|
Bejanyan, Nelli
|
|
|
|
5 |
p. 1154-1163
|
artikel
|
| 14 |
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study
|
Enshaei, Amir
|
|
|
|
5 |
p. 1155-1166
|
artikel
|
| 15 |
Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis
|
Staron, Andrew
|
|
|
|
5 |
p. 880-884
|
artikel
|
| 16 |
Association between hemoglobin values and VWF assays: a multicenter investigation
|
Simoneau, Jillian
|
|
|
|
5 |
p. 1152-1154
|
artikel
|
| 17 |
A sweet deal: blocking NMDAR for safer t-PA in diabetes
|
Denorme, Frederik
|
|
|
|
5 |
p. 1328-1329
|
artikel
|
| 18 |
Bennewitz MF, Tutuncuoglu E, Gudapati S, et al. P-selectin–deficient mice to study pathophysiology of sickle cell disease. Blood Adv. 2020;4(2):266-273.
|
|
|
|
|
5 |
p. 803
|
artikel
|
| 19 |
Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation
|
Tey, Siok-Keen
|
|
|
|
5 |
p. 1619-1622
|
artikel
|
| 20 |
Bleeding in patients with sickle cell disease: a population-based study
|
Hariharan, Nisha
|
|
|
|
5 |
p. 793-802
|
artikel
|
| 21 |
Burden of employment loss and absenteeism in adults and caregivers of children with sickle cell disease
|
Gordon, Rachel D’Amico
|
|
|
|
5 |
p. 1143-1150
|
artikel
|
| 22 |
CAMK2G is identified as a novel therapeutic target for myelofibrosis
|
Miyauchi, Masashi
|
|
|
|
5 |
p. 1585-1597
|
artikel
|
| 23 |
CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine
|
Fanciullino, Raphaelle
|
|
|
|
5 |
p. 462-469
|
artikel
|
| 24 |
CD14+/CD31+ monocytes expanded by UM171 correct hemophilia A in zebrafish upon lentiviral gene transfer of factor VIII
|
Elnaggar, Muhammad
|
|
|
|
5 |
p. 697-711
|
artikel
|
| 25 |
Characterization and statistical modeling of glycosylation changes in sickle cell disease
|
Ashwood, Heather E.
|
|
|
|
5 |
p. 1463-1473
|
artikel
|
| 26 |
Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia
|
Grover, Punita
|
|
|
|
5 |
p. 1608-1618
|
artikel
|
| 27 |
Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
|
Stahl, Maximilian
|
|
|
|
5 |
p. 1552-1564
|
artikel
|
| 28 |
Clinical developments in epigenetic-directed therapies in acute myeloid leukemia
|
Pan, Darren
|
|
|
|
5 |
p. 970-982
|
artikel
|
| 29 |
Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era
|
Khurana, Arushi
|
|
|
|
5 |
p. 1379-1387
|
artikel
|
| 30 |
CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation
|
Bartholdy, Boris A.
|
|
|
|
5 |
p. 893-905
|
artikel
|
| 31 |
Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post–autologous stem cell transplantation
|
Soerensen, Johannes Frasez
|
|
|
|
5 |
p. 885-892
|
artikel
|
| 32 |
Comorbidities and malignancies negatively affect survival in myelodysplastic syndromes: a population-based study
|
Rozema, Johanne
|
|
|
|
5 |
p. 1344-1351
|
artikel
|
| 33 |
Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas
|
Koh, Min Jung
|
|
|
|
5 |
p. 1420-1431
|
artikel
|
| 34 |
Complete correction of hemophilia B phenotype by FIX-Padua skeletal muscle gene therapy in an inhibitor-prone dog model
|
French, Robert A.
|
|
|
|
5 |
p. 505-508
|
artikel
|
| 35 |
Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models
|
Tarantelli, Chiara
|
|
|
|
5 |
p. 819-829
|
artikel
|
| 36 |
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells
|
Pavani, Giulia
|
|
|
|
5 |
p. 1137-1153
|
artikel
|
| 37 |
Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
|
Potnis, Kunal C.
|
|
|
|
5 |
p. 801-810
|
artikel
|
| 38 |
Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis
|
van Dam, Lisette F.
|
|
|
|
5 |
p. 1369-1378
|
artikel
|
| 39 |
Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv. 2021;5(20):3951-3959.
|
|
|
|
|
5 |
p. 811
|
artikel
|
| 40 |
Defining the impact of immune tolerance induction on clinically relevant outcomes in a US cohort of severe hemophilia A
|
Kempton, Christine L.
|
|
|
|
5 |
p. 1190-1199
|
artikel
|
| 41 |
Deregulated expression of circular RNAs in acute myeloid leukemia
|
Lux, Susanne
|
|
|
|
5 |
p. 1490-1503
|
artikel
|
| 42 |
Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia
|
Reina-Castillón, Judith
|
|
|
|
5 |
p. 319-329
|
artikel
|
| 43 |
Development of luspatercept to treat ineffective erythropoiesis
|
Kubasch, Anne Sophie
|
|
|
|
5 |
p. 1565-1575
|
artikel
|
| 44 |
Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis
|
Toya, Takashi
|
|
|
|
5 |
p. 1084-1093
|
artikel
|
| 45 |
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study
|
Middeke, Jan M.
|
|
|
|
5 |
p. 1394-1405
|
artikel
|
| 46 |
Disruption of CSF-1R signaling inhibits growth of AML with inv(16)
|
Simonis, Alexander
|
|
|
|
5 |
p. 1273-1277
|
artikel
|
| 47 |
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS
|
de Jonge, A. Vera
|
|
|
|
5 |
p. 1094-1104
|
artikel
|
| 48 |
Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphoma
|
Portell, Craig A.
|
|
|
|
5 |
p. 1490-1498
|
artikel
|
| 49 |
Downregulated KLF2 in polycythemia vera and essential thrombocythemia induces prothrombotic gene expression
|
Song, Jihyun
|
|
|
|
5 |
p. 712-717
|
artikel
|
| 50 |
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study
|
Wistinghausen, Birte
|
|
|
|
5 |
p. 1116-1127
|
artikel
|
| 51 |
Early detection of treatment failure and early rescue intervention in multiple myeloma: time for new approaches
|
Lahuerta, Juan José
|
|
|
|
5 |
p. 1340-1343
|
artikel
|
| 52 |
Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML
|
Terao, Toshiki
|
|
|
|
5 |
p. 681-686
|
artikel
|
| 53 |
Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT
|
Mizuno, Kana
|
|
|
|
5 |
p. 1454-1463
|
artikel
|
| 54 |
Editorial Board
|
|
|
|
|
5 |
p. i
|
artikel
|
| 55 |
Editorial Board
|
|
|
|
|
5 |
p. i
|
artikel
|
| 56 |
Editorial Board
|
|
|
|
|
5 |
p. i
|
artikel
|
| 57 |
Editorial Board
|
|
|
|
|
5 |
p. i
|
artikel
|
| 58 |
Editorial Board
|
|
|
|
|
5 |
p. i
|
artikel
|
| 59 |
Editorial Board
|
|
|
|
|
5 |
p. i
|
artikel
|
| 60 |
Editorial Board
|
|
|
|
|
5 |
p. i
|
artikel
|
| 61 |
Effectiveness and safety of prophylactic anticoagulation among hospitalized patients with inflammatory bowel disease
|
Dawwas, Ghadeer K.
|
|
|
|
5 |
p. 1272-1280
|
artikel
|
| 62 |
Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL
|
Graf, Solomon A.
|
|
|
|
5 |
p. 687-696
|
artikel
|
| 63 |
End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA
|
Kostakoglu, Lale
|
|
|
|
5 |
p. 1283-1290
|
artikel
|
| 64 |
Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein
|
Das, Rupali
|
|
|
|
5 |
p. 813-824
|
artikel
|
| 65 |
Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants
|
Samelson-Jones, Benjamin J.
|
|
|
|
5 |
p. 1324-1332
|
artikel
|
| 66 |
Expansion of IL-17A–secreting CD8+ mucosa-associated invariant T cells in peripheral blood following stem cell mobilization
|
Varelias, Antiopi
|
|
|
|
5 |
p. 718-723
|
artikel
|
| 67 |
Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation
|
de Koning, Coco
|
|
|
|
5 |
p. 565-574
|
artikel
|
| 68 |
First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings
|
MacMillan, Margaret L.
|
|
|
|
5 |
p. 1425-1436
|
artikel
|
| 69 |
Francica JR, Zak DE, Linde C, et al. Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs. Blood Adv. 2017;1(25):2329-2342.
|
|
|
|
|
5 |
p. 516
|
artikel
|
| 70 |
Front Matter
|
|
|
|
|
5 |
p. ii
|
artikel
|
| 71 |
Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion
|
Tretti Parenzan, Caterina
|
|
|
|
5 |
p. 1305-1319
|
artikel
|
| 72 |
FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice
|
Merlin, Simone
|
|
|
|
5 |
p. 825-838
|
artikel
|
| 73 |
GATA2 deficiency elevates interferon regulatory factor-8 to subvert a progenitor cell differentiation program
|
Johnson, Kirby D.
|
|
|
|
5 |
p. 1464-1473
|
artikel
|
| 74 |
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis
|
Rontauroli, Sebastiano
|
|
|
|
5 |
p. 1452-1462
|
artikel
|
| 75 |
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia
|
Walker, Christopher J.
|
|
|
|
5 |
p. 1474-1482
|
artikel
|
| 76 |
Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia
|
Iglesias, Pablo
|
|
|
|
5 |
p. 1209-1223
|
artikel
|
| 77 |
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study
|
Luque Paz, Damien
|
|
|
|
5 |
p. 1442-1451
|
artikel
|
| 78 |
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia
|
Pierini, Antonio
|
|
|
|
5 |
p. 1199-1208
|
artikel
|
| 79 |
Health care costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective
|
Maziarz, Richard T.
|
|
|
|
5 |
p. 1200-1208
|
artikel
|
| 80 |
Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity
|
Courjon, Johan
|
|
|
|
5 |
p. 1523-1534
|
artikel
|
| 81 |
High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant
|
Gebhart, Johanna
|
|
|
|
5 |
p. 769-776
|
artikel
|
| 82 |
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
|
Bourbon, Estelle
|
|
|
|
5 |
p. 744-755
|
artikel
|
| 83 |
HLA-haploidentical TCRαβ+/CD19+-depleted stem cell transplantation in children and young adults with Fanconi anemia
|
Strocchio, Luisa
|
|
|
|
5 |
p. 1333-1339
|
artikel
|
| 84 |
Human megakaryocytic microparticles induce de novo platelet biogenesis in a wild-type murine model
|
Escobar, Christian
|
|
|
|
5 |
p. 804-814
|
artikel
|
| 85 |
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study
|
Tivey, Ann
|
|
|
|
5 |
p. 1209-1219
|
artikel
|
| 86 |
Identification of enhancer of mRNA decapping 4 as a novel fusion partner of MLL in acute myeloid leukemia
|
Becker, Heiko
|
|
|
|
5 |
p. 761-765
|
artikel
|
| 87 |
Identification of germline variants in adults with hemophagocytic lymphohistiocytosis
|
Miller, Peter G.
|
|
|
|
5 |
p. 925-929
|
artikel
|
| 88 |
IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells
|
Rai, Shivam
|
|
|
|
5 |
p. 1234-1249
|
artikel
|
| 89 |
IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation
|
Li, Shirong
|
|
|
|
5 |
p. 492-504
|
artikel
|
| 90 |
Impact of event-free survival status after stem cell transplantation on subsequent survival of patients with lymphoma
|
Fujimoto, Ayumi
|
|
|
|
5 |
p. 1412-1424
|
artikel
|
| 91 |
Impact of vitamin D level at diagnosis and transplantation on the prognosis of hematological malignancy: a meta-analysis
|
Ito, Yusuke
|
|
|
|
5 |
p. 1499-1511
|
artikel
|
| 92 |
Improving stroke outcomes in hyperglycemic mice by modulating tPA/NMDAR signaling to reduce inflammation and hemorrhages
|
Lebrun, Florent
|
|
|
|
5 |
p. 1330-1344
|
artikel
|
| 93 |
Inactivation of platelet-derived TGF-β1 attenuates aortic stenosis progression in a robust murine model
|
Varshney, Rohan
|
|
|
|
5 |
p. 777-788
|
artikel
|
| 94 |
Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation
|
Marcoux, Curtis
|
|
|
|
5 |
p. 1128-1136
|
artikel
|
| 95 |
Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice
|
Avellino, Roberto
|
|
|
|
5 |
p. 1406-1419
|
artikel
|
| 96 |
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma
|
Ziccheddu, Bachisio
|
|
|
|
5 |
p. 830-844
|
artikel
|
| 97 |
Interleukin-2–inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells
|
Mamand, Sami
|
|
|
|
5 |
p. 705-710
|
artikel
|
| 98 |
Langerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant
|
Chung, David J.
|
|
|
|
5 |
p. 1547-1558
|
artikel
|
| 99 |
Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
|
Ekberg, Sara
|
|
|
|
5 |
p. 866-874
|
artikel
|
| 100 |
Latent human cytomegalovirus enhances HIV-1 infection in CD34+ progenitor cells
|
Cheung, Allen Ka Loon
|
|
|
|
5 |
p. 306-318
|
artikel
|
| 101 |
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma
|
Bewicke-Copley, Findlay
|
|
|
|
5 |
p. 845-855
|
artikel
|
| 102 |
Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines
|
Moccia, Alden A.
|
|
|
|
5 |
p. 1483-1489
|
artikel
|
| 103 |
Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trial
|
Tang, Yaqiong
|
|
|
|
5 |
p. 1250-1258
|
artikel
|
| 104 |
Lévy R, Fusaro M, Guerin F, et al. Efficacy of ruxolitinib in subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis. Blood Adv. 2020;4(7):1383-1387.
|
|
|
|
|
5 |
p. 800
|
artikel
|
| 105 |
M-CSFR/CSF1R signaling regulates myeloid fates in zebrafish via distinct action of its receptors and ligands
|
Hason, Martina
|
|
|
|
5 |
p. 1474-1488
|
artikel
|
| 106 |
MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease
|
Demers, Melanie
|
|
|
|
5 |
p. 1388-1402
|
artikel
|
| 107 |
Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma
|
Diefenbach, Catherine S.
|
|
|
|
5 |
p. 1194-1198
|
artikel
|
| 108 |
Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells
|
Kinsella, Francesca A.M.
|
|
|
|
5 |
p. 734-743
|
artikel
|
| 109 |
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia
|
Fobare, Sydney
|
|
|
|
5 |
p. 1371-1380
|
artikel
|
| 110 |
Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status
|
Shrestha, Raksha
|
|
|
|
5 |
p. 845-854
|
artikel
|
| 111 |
Molecular response to imatinib in patients with chronic myeloid leukemia in Tanzania
|
Nasser, Ahlam
|
|
|
|
5 |
p. 1403-1411
|
artikel
|
| 112 |
Monoallelic loss-of-function THPO variants cause heritable thrombocytopenia
|
Cornish, Naomi
|
|
|
|
5 |
p. 920-924
|
artikel
|
| 113 |
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML
|
Chan, Onyee
|
|
|
|
5 |
p. 1075-1083
|
artikel
|
| 114 |
Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas
|
Nagy, Alexandra
|
|
|
|
5 |
p. 481-491
|
artikel
|
| 115 |
Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation
|
Deeg, H. Joachim
|
|
|
|
5 |
p. 1623-1627
|
artikel
|
| 116 |
Oñate G, Bataller A, Garrido A, et al; CETLAM (Spanish Cooperative Group for the Diagnosis and Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes). Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1. Blood Adv. 2022;6(3):882-890.
|
|
|
|
|
5 |
p. 875
|
artikel
|
| 117 |
Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model
|
Thirukkumaran, Chandini M.
|
|
|
|
5 |
p. 797-812
|
artikel
|
| 118 |
Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol
|
Rajendra, Akhil
|
|
|
|
5 |
p. 1178-1193
|
artikel
|
| 119 |
Outcomes of a clinician-directed protocol for discontinuation of complement inhibition therapy in atypical hemolytic uremic syndrome
|
Chaturvedi, Shruti
|
|
|
|
5 |
p. 1504-1512
|
artikel
|
| 120 |
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN
|
Davidson, Marta B.
|
|
|
|
5 |
p. 1281-1294
|
artikel
|
| 121 |
Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab
|
Wudhikarn, Kitsada
|
|
|
|
5 |
p. 1432-1443
|
artikel
|
| 122 |
Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma
|
Tandon, Nidhi
|
|
|
|
5 |
p. 744-750
|
artikel
|
| 123 |
Patient-specific comorbidities as prognostic variables for survival in myelofibrosis
|
Sochacki, Andrew L.
|
|
|
|
5 |
p. 756-767
|
artikel
|
| 124 |
Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines
|
Etxeandia-Ikobaltzeta, Itziar
|
|
|
|
5 |
p. 953-968
|
artikel
|
| 125 |
Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy
|
Burlile, Jessica F.
|
|
|
|
5 |
p. 1250-1257
|
artikel
|
| 126 |
Pediatric transplant–associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy
|
Schoettler, Michelle L.
|
|
|
|
5 |
p. 1220-1233
|
artikel
|
| 127 |
Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study
|
Ali, Haris
|
|
|
|
5 |
p. 1444-1453
|
artikel
|
| 128 |
Pharmacologic control of CAR-T cell function using dasatinib
|
Weber, Evan W.
|
|
|
|
5 |
p. 711-717
|
artikel
|
| 129 |
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma
|
Frigault, Matthew J.
|
|
|
|
5 |
p. 768-777
|
artikel
|
| 130 |
Platelets as drivers of ischemia/reperfusion injury after stroke
|
Shaik, Noor F.
|
|
|
|
5 |
p. 1576-1584
|
artikel
|
| 131 |
Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunity
|
Schroeder, Jocelyn A.
|
|
|
|
5 |
p. 1224-1238
|
artikel
|
| 132 |
Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury
|
Ghafoory, Shahrouz
|
|
|
|
5 |
p. 470-480
|
artikel
|
| 133 |
Population pharmacokinetics of the von Willebrand factor–factor VIII interaction in patients with von Willebrand disease
|
Bukkems, Laura H.
|
|
|
|
5 |
p. 1513-1522
|
artikel
|
| 134 |
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia
|
Tran, Thai Hoa
|
|
|
|
5 |
p. 529-533
|
artikel
|
| 135 |
Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk
|
Witalis, Mariko
|
|
|
|
5 |
p. 868-879
|
artikel
|
| 136 |
Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infections
|
Subramaniam, Nirojah
|
|
|
|
5 |
p. 1259-1272
|
artikel
|
| 137 |
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
|
Haggenburg, Sabine
|
|
|
|
5 |
p. 1537-1546
|
artikel
|
| 138 |
Recombinant erythropoietin in autoimmune hemolytic anemia with inadequate bone marrow response: a prospective analysis
|
Fattizzo, Bruno
|
|
|
|
5 |
p. 1322-1327
|
artikel
|
| 139 |
Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide
|
DeZern, Amy E.
|
|
|
|
5 |
p. 1360-1368
|
artikel
|
| 140 |
Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma
|
Merryman, Reid W.
|
|
|
|
5 |
p. 858-867
|
artikel
|
| 141 |
RNA-seq–based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia
|
Kubota, Hirohito
|
|
|
|
5 |
p. 1258-1271
|
artikel
|
| 142 |
RUNX transcription factors potentially control E-selectin expression in the bone marrow vascular niche in mice
|
Morita, Ken
|
|
|
|
5 |
p. 509-515
|
artikel
|
| 143 |
SARS-CoV-2–neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma
|
Malin, Jakob J.
|
|
|
|
5 |
p. 1580-1584
|
artikel
|
| 144 |
SARS-CoV-2–specific T-cell responses to recurrent COVID-19 pneumonitis in a patient with post-CART B-cell aplasia
|
Hodder, Angus
|
|
|
|
5 |
p. 1577-1579
|
artikel
|
| 145 |
sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study
|
Wimmer, Thomas
|
|
|
|
5 |
p. 832-844
|
artikel
|
| 146 |
Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea
|
Wang, Rong
|
|
|
|
5 |
p. 734-743
|
artikel
|
| 147 |
Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study
|
Qin, Xiao-Qi
|
|
|
|
5 |
p. 751-760
|
artikel
|
| 148 |
Sickle cell disease promotes sex-dependent pathological bone loss through enhanced cathepsin proteolytic activity in mice
|
Selma, Jada
|
|
|
|
5 |
p. 1381-1393
|
artikel
|
| 149 |
Single-cell DNA sequencing reveals complex mechanisms of resistance to quizartinib
|
Peretz, Cheryl A.C.
|
|
|
|
5 |
p. 1437-1441
|
artikel
|
| 150 |
Single-cell mutational profiling enhances the clinical evaluation of AML MRD
|
Ediriwickrema, Asiri
|
|
|
|
5 |
p. 943-952
|
artikel
|
| 151 |
Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD
|
Bader, Cameron S.
|
|
|
|
5 |
p. 1105-1115
|
artikel
|
| 152 |
Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice
|
Li, Chang
|
|
|
|
5 |
p. 1239-1249
|
artikel
|
| 153 |
Sipa1 deficiency–induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm
|
Xiao, Pingnan
|
|
|
|
5 |
p. 534-548
|
artikel
|
| 154 |
Spatiotemporal assessment of immunogenomic heterogeneity in multiple myeloma
|
Merz, Maximilian
|
|
|
|
5 |
p. 718-733
|
artikel
|
| 155 |
Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes
|
El Jurdi, Najla
|
|
|
|
5 |
p. 1352-1359
|
artikel
|
| 156 |
Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia: a Danish population-based study
|
Øvlisen, Andreas K.
|
|
|
|
5 |
p. 559-564
|
artikel
|
| 157 |
Structures of human plasma β–factor XIIa cocrystallized with potent inhibitors
|
Dementiev, Alexey
|
|
|
|
5 |
p. 549-558
|
artikel
|
| 158 |
Successfully treated thrombocytopenia following allogeneic transplant with daratumumab: a case report and literature review
|
Migdady, Yazan
|
|
|
|
5 |
p. 815-818
|
artikel
|
| 159 |
Systemic inflammation induces release of cell-free DNA from hematopoietic and parenchymal cells in mice and humans
|
van der Meer, Anne Jan
|
|
|
|
5 |
p. 724-728
|
artikel
|
| 160 |
Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias
|
Branagan, Andrew R.
|
|
|
|
5 |
p. 1535-1539
|
artikel
|
| 161 |
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia
|
Brown, Lauren M.
|
|
|
|
5 |
p. 930-942
|
artikel
|
| 162 |
The changing landscape of anticoagulation in cancer-associated thrombosis
|
Lee, Agnes Y.Y.
|
|
|
|
5 |
p. 969
|
artikel
|
| 163 |
The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages
|
Verbij, Fabian C.
|
|
|
|
5 |
p. 293-305
|
artikel
|
| 164 |
The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
|
Sacks, Naomi C.
|
|
|
|
5 |
p. 1566-1576
|
artikel
|
| 165 |
The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-associated vasculitis
|
Busch, Matthias H.
|
|
|
|
5 |
p. 1295-1304
|
artikel
|
| 166 |
The Lucky Iron Fish: a simple solution for iron deficiency
|
Armstrong, Gavin R.
|
|
|
|
5 |
p. 330
|
artikel
|
| 167 |
The molecular hallmarks of primary and secondary vitreoretinal lymphoma
|
Bonzheim, Irina
|
|
|
|
5 |
p. 1598-1607
|
artikel
|
| 168 |
The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients
|
Sourisseau, Mathilde
|
|
|
|
5 |
p. 856-865
|
artikel
|
| 169 |
The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A
|
Wu, Shang-Chuen
|
|
|
|
5 |
p. 1305-1309
|
artikel
|
| 170 |
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT
|
Shouval, Roni
|
|
|
|
5 |
p. 1525-1535
|
artikel
|
| 171 |
Tiong IS, Dillon R, Ivey A, et al. Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia. Blood Adv. 2021;5(23):5107-5111.
|
|
|
|
|
5 |
p. 1489
|
artikel
|
| 172 |
Total knee replacement with and without emicizumab: a unique comparison of perioperative management
|
Evans, Matthew S.
|
|
|
|
5 |
p. 855-857
|
artikel
|
| 173 |
Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease
|
Hosoya, Hitomi
|
|
|
|
5 |
p. 575-585
|
artikel
|
| 174 |
Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing
|
Huisman, W.
|
|
|
|
5 |
p. 812-827
|
artikel
|
| 175 |
Tranexamic acid is an active site inhibitor of urokinase plasminogen activator
|
Wu, Guojie
|
|
|
|
5 |
p. 729-733
|
artikel
|
| 176 |
Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load
|
Eddins, Devon J.
|
|
|
|
5 |
p. 778-799
|
artikel
|
| 177 |
Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis
|
Renosi, Florian
|
|
|
|
5 |
p. 1540-1551
|
artikel
|
| 178 |
Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy
|
Abbas, Hussein A.
|
|
|
|
5 |
p. 828-831
|
artikel
|
| 179 |
Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
|
Chiesa, Robert
|
|
|
|
5 |
p. 1512-1524
|
artikel
|
| 180 |
Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis
|
Khatib, Rasha
|
|
|
|
5 |
p. 789-796
|
artikel
|
| 181 |
Weisdorf D, Cooley S, Wang T, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Adv. 2020;4(4):740-754.
|
|
|
|
|
5 |
p. 1536
|
artikel
|
| 182 |
Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patients
|
Tamagne, Marie
|
|
|
|
5 |
p. 1278-1282
|
artikel
|
| 183 |
Wu J, Moriwaki K, Asuka T, et al. EHBP1L1, an apicobasal polarity regulator, is critical for nuclear polarization during enucleation of erythroblasts. Blood Adv. 2023;7(14):3382–3394.
|
|
|
|
|
5 |
p. 1151
|
artikel
|
| 184 |
ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV–unmutated chronic lymphocytic leukemia
|
Chen, Jingyu
|
|
|
|
5 |
p. 1167-1178
|
artikel
|
Tijdschrift beschrijving